Welcome to the European Association for Cancer Research
Connecting cancer researchers together
Liquid Biopsies
Lyon, France : 22 - 24 September 2026
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Summer Time (CEST)
REGISTRATION
Light refreshments will be served at 12:00
CONFERENCE WELCOME
Session 1: Unveiling the biology beneath the biomarkers: Mechanisms driving liquid biopsy signals
Chair: Ellen Heitzer
OPENING KEYNOTE LECTURE
Efrat Shema Weizmann Institute of Science, Israel
'Single-molecule epigenetic analysis of plasma-circulating nucleosomes for cancer diagnosis'
Q&A 13:40-13:55
Amin El-Heliebi Med Uni Graz, Austria
'Integrating liquid biopsy and spatial transcriptomics for understanding ctDNA release'
Q&A 14:15-14:25
Proferred Paper 1
Q&A 14:35-14:40
EXHIBITOR INTRODUCTIONS
COFFEE BREAK, EXHIBITION AND SOLO TRAVELLERS' MEET-UP
Remond Fijneman NKI, Netherlands
'Impact of tumor location and host factors on ctDNA shedding'
Q&A 15:40-15:50
David Lyden Weill Cornell Medicine, USA
Q&A 16:10-16:20
POSTER SPOTLIGHTS
INDUSTRY SYMPOSIUM - biomodal
PANEL DISCUSSION
'Where is liquid biopsy heading in the next 5–10 years? Clinical implementation, standardization and regulatory challenges'
WELCOME RECEPTION
POSTER DISCUSSION SESSION 1
Led by members of the Scientific Programme Committee
Listed times are in Central European Summer Time (CEST)
EARLY POSTER VIEWING
Chair: Claus Lindbjerg Andersen
INDUSTRY SPOTLIGHT - Ultima Genomics
Session 2: Tracking the unseen: Liquid biopsies in advanced and metastatic cancer
Karen-Lise Garm Spindler Aarhus University, Denmark
'Using ctDNA for response evaluation in solid tumors – a paradigm shift in medical oncology?'
Q&A 9:20-9:30
Proferred Paper 2
Q&A 09:40-09:45
Ellen Heitzer Meduni Graz, Austria
'Signal vs Noise: The Reality of ctDNA in Advanced Disease'
Q&A 10:05-10:15
Irene Casanova VHIO, Spain
'EV-enhanced liquid biopsy for tumor dynamics in metastatic Prostate Cancer'
Q&A 10:35-10:45
COFFEE BREAK AND EXHIBITION
François Clément Bidard Institut Curie & UVSQ/Université Paris-Saclay, France
'Intercepting late resistance to therapy with ctDNA: ESR1 mutations and beyond'
Q&A 11:35-11:45
Proferred Paper 3
Q&A 11:55-12:00
POSTER SPOTLIGHTS
INDUSTRY SYMPOSIUM - Becton Dickinson
LUNCH
POSTER DISCUSSION SESSION 2
Led by members of the Scientific Programme Committee
Session 3: Frontiers in liquid biopsy technology: From fragmentomics to functional readouts
Chair: Nikolas Stoecklein
Mette Aaegebeck University of Copenhagen, Denmark
'Oncofetal Chondroitin Sulfate: A circulating biomarker on tumour-derived CTCs, EVs, and soluble proteoglycans'
Q&A 15:20-15:30
Proferred Paper 4
Q&A 15:40-15:45
Proferred Paper 5
Q&A 15:55-16:00
Nikolas H. Stoecklein University of Dusseldorf, Germany
'From Milliliters to Liters of Blood: Diagnostic Leukapheresis as a Platform for Scaled CTC Discovery and Translation'
Q&A 16:20-16:30
COFFEE BREAK AND EXHIBITION
An Hendrix Ghent University, Belgium
Q&A 17:20-17:30
Anders Jacobsen Skanderup Genome Institute of Singapore, Singapore
'Pushing the Limits: Enhancing Detection and Quantification in Tumour-Naive Liquid Biopsies'
Q&A 17:50-18:00
PANEL DISCUSSION
'Publication strategies and the responsible use of AI in scientific writing'
Scheduled to end at 18:45
CONFERENCE DINNER (OPTIONAL TICKETED EVENT)
Listed times are in Central European Summer Time (CEST)
EARLY POSTER VIEWING
Chair: An Hendrix
INDUSTRY SPOTLIGHT - Particle Metrix
Session 4: Liquid insights at the earliest stage: Transforming localised cancer detection and intervention
Angela DeMichele Penn Medicine, USA
'ctDNA in the neoadjuvant and adjuvant management of breast cancer: the quest for clinical utility'
Q&A 09:20-09:30
Claus Lindbjerg Andersen Aarhus University, Denmark
'From Resection to Recurrence Prediction: The Role of Liquid Biopsy in CRC Management'
Q&A 09:50-10:00
Proferred Paper 6
Q&A 10:10-10:15
COFFEE BREAK AND EXHIBITION
Nickolas Papadopoulos John Hopkins Medicine, USA
Q&A 11:05-11:15
CLOSING KEYNOTE LECTURE
Maximilian Diehn Stanford University, USA
'Analysis of cell-free RNA for cancer detection and characterization'
Q&A 11:45-12:00
SUMMARY AND CLOSE
Key dates
Travel Grant application deadline:
29 June 2026
Abstract submission deadline:
29 June 2026
Registration and Payment deadline:
17 August 2026
